imiquimod has been researched along with Carcinogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blauvelt, A; Boki, H; Kimura, T; Miyagaki, T; Okochi, H; Sato, S; Suga, H; Sugaya, M | 1 |
| Cho, SD; Han, JH; Kang, MJ; Kim, B; Kim, BY; Kim, DJ; Kim, JB; Park, JH; Park, SY | 1 |
2 other study(ies) available for imiquimod and Carcinogenesis
| Article | Year |
|---|---|
Lymphatic Dysfunction Exacerbates Cutaneous Tumorigenesis and Psoriasis-Like Skin Inflammation through Accumulation of Inflammatory Cytokines.
Topics: Animals; Carcinogenesis; Cytokines; Dermatitis; Disease Models, Animal; Imiquimod; Inflammation; Lymphatic System; Mice; Mice, Inbred BALB C; Psoriasis; Skin | 2022 |
TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells.
Topics: Adenocarcinoma; Aminoquinolines; Animals; Antineoplastic Agents; Carcinogenesis; Cell Growth Processes; Cell Line, Tumor; Cytokines; Disease Models, Animal; Disease Susceptibility; Epithelial Cells; Gene Expression Regulation, Neoplastic; Guanosine; Humans; Imiquimod; Inflammation Mediators; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Prostate; Prostatic Neoplasms; Toll-Like Receptor 7; Transgenes; Tumor Stem Cell Assay | 2013 |